Mathematical Models and AI Join Forces to Build a Global Shield Against Viral Syndemics

A systematic review published in New Microbes and New Infections argues that the world’s best defence against the next pandemic lies not in any single technology but in the deliberate fusion of two computational traditions: classical mathematical modelling of disease transmission and modern artificial intelligence. Led by Romina Cabrera-Rodríguez, Agustin Valenzuela-Fernández and Rodrigo Trujillo-González, the review synthesises literature spanning more than three decades and proposes an integrated architecture, dubbed the “Silicon Shield”, in which mechanistic epidemiology, deep learning and social vulnerability data operate as one coordinated early-warning and response system.

The urgency of the review is grounded in the changing character of viral threats. Roughly 60% of emerging infectious diseases originate as zoonoses, and 72% of those derive from wildlife reservoirs. The past two decades delivered SARS-CoV, H1N1 influenza, MERS-CoV, Ebola, Zika and SARS-CoV-2 in rapid succession, and recent events, including a Bundibugyo virus outbreak in the Democratic Republic of the Congo that spread to Uganda and prompted a World Health Organization emergency declaration, together with an Andes virus cluster aboard the cruise vessel MV Hondius, illustrate how mobility, urban density and humanitarian crises accelerate dissemination. The authors emphasise that these events are syndemics rather than simple epidemics: pathogens interact synergistically with poverty, structural inequality and chronic disease burden, compounding health and economic damage in ways that purely biological models fail to capture.

A central vulnerability the review identifies is the countermeasure gap during the earliest phase of any outbreak. Traditional vaccine development takes 10 to 15 years, and even the accelerated COVID-19 effort required roughly 11 months from genome sequencing to emergency authorisation. Infectious disease therapeutics have a median clinical development time of 7.3 years. Diagnostics pose an equally severe problem, because targeted assays such as multiplex PCR depend on prior knowledge of a pathogen’s genome or antigens, meaning a genuinely novel virus goes undetected. Metagenomic next-generation sequencing offers an agnostic alternative that can sequence all nucleic acids in a sample without prior assumptions, but it suffers from lower sensitivity at low viral loads, complex bioinformatics, high costs and limited availability precisely in the low- and middle-income regions where most spillovers originate.

To quantify transmission, the review returns to the compartmental foundations laid by Ross, Hamer and the Kermack-McKendrick SIR model of 1927, extended to the SEIR framework that adds an exposed class for diseases with incubation periods. These models are systems of non-linear ordinary differential equations whose behaviour is analysed through equilibrium and stability theory: the disease-free and endemic equilibria are assessed by linearising the system and examining the eigenvalues of the Jacobian matrix, with negative real parts indicating that an outbreak will dissipate. The pivotal parameter is the basic reproduction number R0, the average number of secondary infections generated by one infectious individual in a fully susceptible population. When R0 exceeds 1, a pathogen can invade; the herd immunity threshold follows as 1 minus 1/R0. The authors caution, however, that R0 is an emergent property of the pathogen-host-environment system rather than a biological constant, and that real-time tracking requires the effective reproduction number Rt, which declines as interventions and behavioural changes take hold.

The choice between deterministic and stochastic modelling matters most where it counts: at the beginning. Deterministic differential-equation models are computationally efficient and describe average trajectories in large populations, whereas stochastic models explicitly incorporate random variation and are critical for small populations, rare events and early outbreak phases, where the two approaches can yield qualitatively different predictions about the probability of a large epidemic. During COVID-19, models that explicitly represented pre-symptomatic and asymptomatic compartments alongside quarantined individuals revealed that these overlooked groups drive substantial transmission, making widespread testing far more effective than symptom-based surveillance alone. At the applied end, agent-based models such as Covasim simulate individuals with realistic demographics, contact networks and viral-load-based transmissibility, and can run full intervention scenarios on a standard laptop in under a minute, which is why health agencies in more than a dozen countries have used them for real-time policy support.

Artificial intelligence extends this toolkit into molecular territory that sequence-homology tools such as BLAST cannot reach. Protein structure predictors like AlphaFold and ESMFold map viral glycoproteins with atomic precision, and machine learning applied to the Flaviviridae family revealed more than 100 previously unrecognised glycoproteins. Convolutional neural networks such as ViraMiner and DeePaC detect highly divergent viral genomes in metagenomic samples that standard alignment approaches label as unknown, while transformer architectures like LucaProt have identified candidate novel RNA virus species from RNA-dependent RNA polymerase sequences. Perhaps most strikingly, the EVEscape framework, trained exclusively on viral sequences available before 2020, anticipated SARS-CoV-2 variation with accuracy comparable to high-throughput experimental antibody-escape scans, and generalises to influenza, HIV, Lassa and Nipah, enabling vaccine designers to target conserved regions less susceptible to evasion.

At the population level, AI-powered surveillance systems parse open-source data to flag anomalies days to weeks before official recognition. HealthMap uses natural language processing and Bayesian machine learning to extract hyperlocal geographic information from multilingual web reports, having provided early indications of H1N1 in Mexico and the 2019 vaping-associated lung disease outbreak, while EpiWatch proved effective during the 2022 global mpox epidemic. One global disease-activity database detected 94% of WHO-identified outbreaks an average of 43.4 days earlier, and Bayesian outbreak detection algorithms have caught influenza surges with only a four-to-five-day delay and minimal false alarms. Wearable devices add another layer: smart-ring data achieved an area under the curve of 0.85 for population-level fever surveillance. In clinical diagnostics, deep learning reaches approximately 96% accuracy for COVID-19 on CT scans and up to 99% for distinguishing COVID-19 from pneumonia on chest X-rays, and multimodal frameworks that combine imaging, tabular and text data outperform single-source models by 6 to 33% across healthcare tasks.

The review is candid about the pitfalls. Hybrid architectures that embed SEIR equations directly into neural network loss functions, so-called physics-informed neural networks, have outperformed purely data-driven models for COVID-19 forecasting, and a technique called epimodulation improved hospital-admission forecast accuracy by an average of 12.3% for COVID-19 and 32.9% for influenza, with the largest gains around epidemic peaks. But deploying streaming models without formal safeguards is risky. The authors highlight uncertainty quantification through Bayesian ensembles and conformal prediction, which reduced diagnostic errors in histopathology from 2% to 0.1% while flagging unreliable predictions for expert review, alongside structural identifiability analysis, simulation-based calibration and automated detection of concept drift, the silent degradation that occurs when the statistical relationship between inputs and outcomes shifts as pathogens and clinical practices evolve. Algorithmic bias compounds these concerns: models trained predominantly on high-income-country data may misclassify patients in low- and middle-income settings, and a systematic review found 87% of machine learning prediction models carried a high risk of bias.

The proposed Silicon Shield is therefore organised as a modular reference architecture across three tiers. A data ingestion layer aggregates molecular streams from metagenomic sequencing pipelines, clinical streams through standardised FHIR APIs, and digital intelligence from NLP engines alongside environmental and mobility data. A model pipeline layer then progresses from unsupervised anomaly detection through evolutionary and immune-escape forecasting to mechanistic transmission modelling coupled with agent-based simulators. A decision interface tier translates outputs into role-specific dashboards for public health officials and explainable clinical decision support for frontline physicians, using techniques such as SHAP to open the black box. Crucially, the framework incorporates social vulnerability indices, which have consistently predicted COVID-19 incidence and mortality, and applies causal inference methods, including directed acyclic graphs and targeted maximum likelihood estimation, to move beyond correlational surveillance toward equity-informed intelligence.

The authors conclude that the technological foundations are largely in place: algorithms capable of processing heterogeneous global data streams, sequencing technologies for rapid pathogen characterisation, and computational infrastructure supporting real-time analytics. What remains is the harder work of building institutional capacity, harmonising incompatible IT systems, navigating legal barriers to data sharing, raising AI literacy in the health workforce and ensuring that surveillance capabilities are distributed equitably rather than concentrated in wealthy nations. Only with sustained, deliberate and fair investment, they argue, can computational capability be translated into genuine public health protection before the next Disease X arrives.

Subject of Research: Integration of mathematical modelling and artificial intelligence for pandemic preparedness against emerging viral syndemics

Article Title: Integrating mathematical modelling and artificial intelligence to combat emerging viral syndemics: A systematic review

Article References: Cabrera-Rodríguez, R., Reyes-Castañeda, I., Lorenzo-Sánchez, I., Valenzuela-Fernández, A., & Trujillo-González, R. (2026). Integrating mathematical modelling and artificial intelligence to combat emerging viral syndemics: A systematic review. New Microbes and New Infections, 74, Article 101843. https://doi.org/10.1016/j.nmni.2026.101843

Image Credits: AI Generated

DOI: 10.1016/j.nmni.2026.101843

Keywords: viral syndemics, mathematical modelling, artificial intelligence, pandemic preparedness, SEIR models, metagenomic sequencing, immune escape prediction, disease surveillance, machine learning diagnostics, social vulnerability, zoonotic spillover, Disease X